BCL2 contributes to the pathogenesis of DLBCL by promoting the survival of B cells, as BCL2-transgenic mice have B cells with extended survival and these mice spontaneously develop aggressive B cell lymphoma (32–34). This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.